SAN DIEGO, Calif., March 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chains, announced today today that its subsidiary Kannaway® will host its European regional event in Prague on March 5-6, 2022.
The event, which will take place at the Wellness Hotel Step, will allow Kannaway® Brand Ambassadors to network with top Kannaway® Europe executives, the company’s global leadership team and other business owners. The company will also launch its first cannabidiol (CBD) product containing 1% THC, which can legally be sold throughout the Czech Republic. Kannaway® CEO Blake Schroeder will be on hand to share company news, interact with brand ambassadors, and more.
“Europe has been a major growth area for Kannaway and these types of events are key in helping people understand the business opportunities to join the company and the value proposition of our products and our company,” said Medical Marijuana, Inc. CEO Blake Schroeder. “These events also provide our Brand Ambassadors with new and innovative tools to increase their success and build stronger relationships with their customers.”
Kannaway® is the first direct selling company to offer hemp-based CBD wellness products in all of Europe. According to market data forecast, the size of the european cannabidiol market is expected to grow at a CAGR of 21.26% between 2021 and 2026 and be worth USD 8.96 billion by 2026, from USD 3.42 billion in 2021.
Kannaway® is a network sales and marketing company specializing in the sale and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, providing unique insight and opportunity for sales professionals who want to become successful leaders in the sale and marketing of botanicals. of hemp.
On Medical MarijuanaInc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct non-psychoactive cannabinoid business units: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in providing the highest quality non-psychoactive legal cannabis products derived from industrial hemp; and a clinical research and development sector for cannabinoid-based botanical drugs led by its pharmaceutical investment companies and partners, including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named one of the top CBD producers by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in developing international markets. The company’s flagship product Genuine Scientific Hemp Oil has been used in several successful clinical studies in Mexico and Brazil to understand its safety and effectiveness.
Medical Marijuana, Inc. is headquartered in San Diego, CA and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To view the Medical Marijuana, Inc. corporate video, Click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by these articles. This document contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. These forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ materially from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Medical Marijuana, Inc. does not sell or distribute any product that violates the United States Controlled Substances Act.
Public relations contact:
#Medical #Marijuana #Subsidiary #Kannaway #Announces #European #Leadership #Product #Launch #Event #Prague